Vaprisol FDA Approval History
FDA Approved: Yes (First approved December 29, 2005)
Brand name: Vaprisol
Generic name: conivaptan hydrochloride
Dosage form: Injection
Company: Astellas Pharma US, Inc.
Treatment for: Hyponatremia
Vaprisol (conivaptan hydrochloride injection) is an arginine vasopressin antagonist for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.
Development Timeline for Vaprisol
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.